Assessment of hypolipidaemic activity of three thiazolidin-4-ones in mice given high-fat diet and fructose

被引:41
作者
Nampurath, Gopalan Kutty [1 ]
Mathew, Surna P. [1 ]
Khanna, Vivek [1 ]
Zachariah, Robby T. [1 ]
Kanji, Surnan [1 ]
Chamallarnudi, Mallikarjuna Rao [1 ]
机构
[1] Manipal Coll Pharmaceut Sci, Dept Pharmacol, Manipal 576104, Karnataka, India
关键词
thiazolidin-4-ones; hypolipidaemic; hypoglycaemic; nicotinic acid; antioxidant;
D O I
10.1016/j.cbi.2007.10.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three 4-thiazolidinones, two with nicotinamide (NAT1 and NAT2) and one with 4-chlorophenoxyacetamide (PAT1) side chains were evaluated for their hypolipidaemic, hypoglycaemic activity in Swiss albino mice fed a high-fat diet along with fructose administered in drinking water. NAT1 and PAT caused reduction of elevated triglycerides, cholesterol and glucose; NAT2 was effective only against triglycerides. Nicotinamide side chain might have contributed to the lipid lowering effect of both NAT1 and NAT2, but the bulky group of the latter could have affected proper binding to the receptor sites, making it ineffective against elevated cholesterol. On the other hand, the 4-chlorophenoxyacetamide side chain of PAT might have exerted powerful hypolipidaemic activity, despite the bulky substitution at C2. As antioxidants, NAT2 and PAT1 showed superior activity, compared to NAT1. The thiazolidinone ring might be responsible for the lipid lowering effect, which is however, modified by the type of substitutions at C2 and N of the ring. Detailed study is warranted to explain the mechanism of action of these compounds as also to make more potent ones. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 11 条
[1]   SERUM-LIPOPROTEINS OF DIABETIC RATS FED A HIGH CHOLESTEROL DIET [J].
ARBEENY, CM ;
EDELSTEIN, D ;
FREEDMAN, SR ;
EDER, HA .
DIABETES, 1980, 29 (10) :774-777
[2]  
Aust S.D, 1978, METHOD ENZYMOL, V52, P306
[3]   THE ANTIOXIDANT BUTYLATED HYDROXYTOLUENE PROTECTS AGAINST ATHEROSCLEROSIS [J].
BJORKHEM, I ;
HENRIKSSONFREYSCHUSS, A ;
BREUER, O ;
DICZFALUSY, U ;
BERGLUND, L ;
HENRIKSSON, P .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :15-22
[4]   Increased hyaluronan and hyaluronidase production and hyaluronan degradation in injured aorta of insulin-resistant rats [J].
Chajara, A ;
Raoudi, M ;
Delpech, B ;
Leroy, M ;
Basuyau, JP ;
Levesque, H .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) :1480-1487
[5]   Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia [J].
Goldberg, A ;
Alagona, P ;
Capuzzi, DM ;
Guyton, J ;
Morgan, JM ;
Rodgers, J ;
Sachson, R ;
Samuel, P .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (09) :1100-1105
[6]   Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy [J].
Grundy, SM .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (04) :294-309
[7]   The effect of high-fat and high-fructose diets on glucose tolerance and plasma lipid and leptin levels in rats [J].
Huang, BW ;
Chiang, MT ;
Yao, HT ;
Chiang, W .
DIABETES OBESITY & METABOLISM, 2004, 6 (02) :120-126
[8]  
Jacob N., 2004, INDIAN DRUGS, V41, P76
[9]  
Joy M.J., 2005, INDIAN DRUGS, V42, P47
[10]  
MAHLEY RW, 2001, GOODMAN GILMANS PHAR, P971